Literature DB >> 22938849

A physiologic-based approach to the evaluation of a patient with hyperphosphatemia.

David E Leaf1, Myles Wolf.   

Abstract

Phosphate is required for skeletal mineralization, cellular energy regulation, synthesis of cell membranes and nucleic acids, and a variety of cell signaling pathways. Extracellular serum phosphate concentration is determined by the balance of gastrointestinal phosphate absorption, skeletal turnover, distribution in intracellular compartments, and renal phosphate excretion. An integrated system of hormones, receptors, and phosphate transporters regulates phosphate homeostasis, and a variety of hereditary and acquired perturbations in these regulators can result in hyperphosphatemia. Although kidney failure is the most common cause of hyperphosphatemia encountered by nephrologists, hyperphosphatemia that presents in patients with early stages of chronic kidney disease or normal kidney function should prompt a detailed evaluation that can be diagnostically challenging. In this teaching case, we describe a case of hyperphosphatemia out of proportion to the degree of decrease in glomerular filtration rate. We present a practical parathyroid hormone-based diagnostic approach that illustrates the current understanding of phosphate regulation in clinically meaningful terms for the practicing nephrologist. Finally, we illustrate how measurement of fibroblast growth factor 23 could be integrated in the future when the test becomes more widely available.
Copyright © 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22938849      PMCID: PMC5505500          DOI: 10.1053/j.ajkd.2012.06.026

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  53 in total

1.  NPT2a--the key to phosphate homeostasis.

Authors:  Henry M Kronenberg
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

Review 2.  Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies.

Authors:  Orlando M Gutiérrez; Myles Wolf
Journal:  Semin Dial       Date:  2010-06-14       Impact factor: 3.455

3.  Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

Authors:  Serge L Ferrari; Jean-Philippe Bonjour; René Rizzoli
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

4.  Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.

Authors:  John P Bilezikian; Aliya Khan; John T Potts; Maria Luisa Brandi; Bart L Clarke; Dolores Shoback; Harald Jüppner; Pierre D'Amour; John Fox; Lars Rejnmark; Leif Mosekilde; Mishaela R Rubin; David Dempster; Rachel Gafni; Michael T Collins; Jim Sliney; James Sanders
Journal:  J Bone Miner Res       Date:  2011-10       Impact factor: 6.741

Review 5.  The role of the extracellular calcium-sensing receptor in health and disease.

Authors:  F Raue; C Haag; E Schulze; K Frank-Raue
Journal:  Exp Clin Endocrinol Diabetes       Date:  2006-09       Impact factor: 2.949

6.  A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis.

Authors:  Tobias Larsson; Xijie Yu; Siobhan I Davis; Mohamad S Draman; Sean D Mooney; Michael J Cullen; Kenneth E White
Journal:  J Clin Endocrinol Metab       Date:  2005-02-01       Impact factor: 5.958

7.  Fatalities and severe metabolic disorders associated with the use of sodium phosphate enemas: a single center's experience.

Authors:  Yaacov Ori; Benaya Rozen-Zvi; Avry Chagnac; Michal Herman; Boris Zingerman; Eli Atar; Uzi Gafter; Asher Korzets
Journal:  Arch Intern Med       Date:  2012-02-13

8.  Intestinal phosphate transport.

Authors:  Yves Sabbagh; Hector Giral; Yupanqui Caldas; Moshe Levi; Susan C Schiavi
Journal:  Adv Chronic Kidney Dis       Date:  2011-03       Impact factor: 3.620

9.  FGF-23 is elevated by chronic hyperphosphatemia.

Authors:  A Gupta; K Winer; M J Econs; S J Marx; M T Collins
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

Review 10.  Diseases associated with the extracellular calcium-sensing receptor.

Authors:  R V Thakker
Journal:  Cell Calcium       Date:  2004-03       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.